VISKEN- pindolol tablet アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

visken- pindolol tablet

novartis pharmaceuticals corporation - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - tablet - 5 mg - visken® (pindolol) is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. visken® (pindolol) is contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings)

VISKEN TABLET カナダ - 英語 - Health Canada

visken tablet

xediton pharmaceuticals inc - pindolol - tablet - 5mg - pindolol 5mg - beta-adrenergic blocking agents

Visken 5 mg tabl. ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visken 5 mg tabl.

novartis pharma sa-nv - pindolol 5 mg - tablet - 5 mg - pindolol 5 mg - pindolol

Visken 15 mg tabl. ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

visken 15 mg tabl.

novartis pharma sa-nv - pindolol 15 mg - tablet - 15 mg - pindolol 15 mg - pindolol

Visken ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

visken

novartis new zealand ltd - pindolol 15mg;   - tablet - 15 mg - active: pindolol 15mg   excipient: magnesium stearate